Ye Chen,Liang Xu,Ruby Yu-Tong Lin,Markus Müschen,H. Phillip Koeffler
Abstract:Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type-specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to understand the role of core transcriptional regulatory circuitry (CRC) in cancer. Specifically, the paper explores the latest progress in computational reconstruction and biological exploration of CRC in different human malignancies, and integrates the strategies and methods for discovering CRC. In addition, the paper also discusses the genetic basis of CRC and its therapeutic vulnerabilities, highlighting the new frontiers of CRC research and the direction of future efforts.
### Core issues of the paper
1. **Definition and characteristics of CRC**:
- Core transcription factors (TFs) form feed - forward transcriptional loops through self - regulation and interconnection, establishing and strengthening gene expression programs for specific cell types.
- CRC, which consists of these core TFs and their regulatory loops, is a key mechanism for maintaining cell identity and state.
2. **Role of CRC in cancer**:
- Abnormal alterations in the cancer genome reprogram the transcriptome to establish and maintain the identity/state of cancerous transformation.
- There is a set of interconnected core TFs in cancer cells, which form feed - forward self - regulatory loops and enhance the expression of oncogenes.
- Cancer - specifically activated core TFs establish the genetic basis of oncogenic CRC by remodeling the epigenome and reconnecting CRC components related to lineages.
3. **Identification and modeling of CRC**:
- CRC is identified by analyzing the genomic binding sites of candidate core TFs and cross - regulation through biological verification.
- Direct targets of core TFs are systematically annotated using techniques such as ChIP - seq.
- Multiple computational programs (such as "CRC Mapper" and "Coltron") have been developed to reconstruct CRC models based on the interconnectivity and self - regulation of TFs in super - enhancer (SEs) regions.
4. **Experimental verification and functional studies**:
- Regulatory loops between core TFs and their functional importance in maintaining cell identity are verified through gene manipulation experiments.
- Studies have shown that disrupting CRC in cancer cells significantly weakens their malignant characteristics and tumorigenicity.
### Specific cases
- **T - cell acute lymphoblastic leukemia (T - ALL)**:
- TAL1, RUNX1, GATA3 and MYB form a positive feed - forward regulatory loop.
- Activation of TAL1 blocks T - cell differentiation and re - activates stem cell genes, leading to malignant transformation.
- **Medulloblastoma**:
- Different subtypes of medulloblastoma have different core TFs modules, such as LEF1, MAF, RUNX2 and EMX2 in the WNT subtype.
- OTX2, NRL and CRX in Group 3 subtype, and LMX1A, LHX2 and EOMES in Group 4 subtype.
- **Neuroblastoma**:
- Three identity modules: PHOX2B, HAND2 and GATA3 in Group 1, AP - 1 TFs (such as FOSL1 and FOSL2) in Group 2, and a mixed module.
- MYCN, PHOX2B, HAND2, GATA3, ISL1 and TBX2 are key - dependent genes, which are crucial for the proliferation and survival of MYCN - amplified neuroblastoma cells.
- **Rhabdomyosarcoma (RMS)**:
- PAX3 - FOXO1 (P3F) in fusion - positive RMS and other core TFs (such as MYOG, MYOD and MYCN) form a myogenic SE loop.
- P3F acts as a pioneer factor to open chromatin, recruit mediator proteins/co - activators, making enhancer loops and transcriptional activation possible.
- **Dedifferentiated Liposarcoma (DDLPS)**:
- FOSL2, MYC and RUNX1 are identified as top - collaborating core TFs.
Through these studies, the paper provides an in - depth understanding of core transcriptional regulatory circuitry in cancer.